Login / Signup

Comparison of Thromboembolic Events Between Pipeline Embolization Device (PED) Shield and PED/PED Flex: A Propensity Score-Matched Analysis.

Felipe Ramirez-VelandiaAlejandro Enriquez-MarulandaJean FiloMichael YoungThomas B FodorDaniel SconzoSandeep MuramJustin H GransteinMax ShutranPhilipp TausskyChristopher S Ogilvy
Published in: Neurosurgery (2024)
This is the first study in the literature performing a propensity scored-matched analysis comparing PED with PED with Shield technology. Our study suggests a trend toward lower thromboembolic events for PED Shield, even after controlling for aspirin and clopidogrel resistance, and a trend toward lower aneurysm retreatment rates with PED Shield, without reaching statistical significance.
Keyphrases
  • systematic review
  • low dose
  • acute coronary syndrome
  • atrial fibrillation
  • type diabetes
  • percutaneous coronary intervention
  • antiplatelet therapy
  • coronary artery disease
  • clinical evaluation